Is Cencora (COR) Undervalued Or Is Raised Guidance Already Priced In?

Cencora has delivered a powerful long run for shareholders, and the question now is whether the current share price lines up with the cash the business can generate. With cash flows in focus, recent gains invite a closer look at what the underlying economics of the company really support. Over the past 5 years Cencora has returned 192.4%, which puts a lot of accumulated optimism on the line if its future cash generation does not keep pace. Management has highlighted a pharmaceutical centric...